Document:

EX-10.4

 Exhibit 10.4 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on November 18, 2021, effective as of January 1, 2022
(the “Effective Date”), by and between MP Materials Corp., a Delaware corporation (the “Company” and, together with any of its direct or indirect subsidiaries, the “Company Group”), and Elliot D.
Hoops (“Executive”): 
 RECITALS 

The Company employed Executive as its General Counsel and Secretary pursuant to the terms and conditions of that certain employment agreement
by and between the Company and Executive, effective as of May 15, 2021 (the “Current Agreement”). 
 The Company
wishes to continue to engage Executive as its General Counsel and Secretary, pursuant to the terms and conditions of this Agreement and Executive desires to be so engaged. The parties wish to replace and supersede the Current Agreement in all
respects with the terms and conditions of this Agreement. 
 NOW, THEREFORE, in consideration of the mutual promises, covenants and
agreements set forth herein, the parties hereto agree as follows: 
 ARTICLE 1. 

EMPLOYMENT AND TERM 

Section 1.1 Employment. The Company agrees to continue to engage Executive in the capacity as General
Counsel and Secretary of the Company and Executive hereby accepts such engagement by the Company upon the terms and conditions specified below. 

Section 1.2 Term. The term of this Agreement shall commence as of the Effective Date and shall
continue until terminated as provided in Article 6 hereof (the “Term”). 
 ARTICLE 2. 

DUTIES OF EXECUTIVE 

Section 2.1 Duties. As General Counsel and Secretary, Executive shall perform all the duties and
obligations generally associated with the position of General Counsel and Secretary subject to the control and supervision of the Chief Executive Officer, and such other executive duties consistent with the foregoing as may be reasonably and
lawfully assigned to him from time to time by the Company. The Executive shall report solely and directly to the Chief Executive Officer. Executive shall perform the services contemplated herein in the best interests of the Company. Executive shall
at all times perform such services in good faith compliance with, and to the extent of his authority, shall to the best of his ability cause the Company to be in compliance with, any and all laws, rules and regulations applicable to the Company of
which Executive is aware. Executive shall, at all times during the Term, in all material respects endeavor to adhere to and obey any and all written internal rules and regulations governing the conduct of the Company’s employees, as established
or modified from time to time; provided, however, in the event of any conflict between the provisions of this Agreement and any such rules or regulations, the provisions of this Agreement shall control. 

  
 -1- 

 Section 2.2 Location of Services. Executive’s
principal place of employment shall be at the Company’s headquarters in Las Vegas, Nevada (subject to any COVID-19 or other variants or other health and safety related restrictions or protocols), or at
such other location or locations and/or remotely as Executive and the Chief Executive Officer shall agree upon. Executive understands he will be required to travel to the Company’s various operations as part of his employment. 

Section 2.3 Exclusive Service. Executive shall devote Executive’s full business time, attention,
skill, and best efforts to the performance of Executive’s duties under this Agreement and shall not engage in any other business or occupation during the Term that (x) conflicts with the interests of the Company or any other member of the
Company Group, (y) interferes materially with the proper and efficient performance of Executive’s duties for the Company or for any other member of the Company Group, or (z) interferes with Executive’s exercise of judgment in the
Company’s best interests. Notwithstanding the foregoing, nothing herein shall preclude Executive from (i) serving as a member of the board of directors or advisory board (or the equivalent in the case of a
non-corporate entity) of any non-competing for-profit business and/or any charitable organizations, (ii) engaging in
charitable activities and community affairs, and (iii) managing Executive’s personal investments and affairs; provided, however, that the activities set out in clauses (i), (ii), and (iii) shall be limited by Executive so as not to
materially interfere, individually or in the aggregate, with the performance of Executive’s duties and responsibilities hereunder. 

ARTICLE 3. 
 COMPENSATION

 Section 3.1 Base Salary. In consideration for Executive’s services hereunder, the
Company shall pay Executive an annual base salary at the rate of Four Hundred Thousand Dollars ($400,000) per year during each year in the Term, subject to increase at the discretion of the Compensation Committee of the Board (the
“Committee”), payable in accordance with the Company’s regular payroll schedule from time to time (less any deductions required for Social Security, state, federal and local withholding taxes, and any other authorized or
mandated similar withholdings). 
 Section 3.2 Annual and Other Bonuses. Executive shall be entitled
to earn bonuses with respect to each year of the Term during which Executive is employed under this Agreement up to not less than 200% of Executive’s base salary, with a target bonus of not less than 100% of Executive’s base salary (such
target bonus, as may be increased from time to time, the “Target Bonus”), determined under the Company’s short-term cash incentive program (the “Bonus Plan”), provided that such percentages are subject
to increase at the discretion of the Committee. Any such bonus shall be based on performance criteria developed by the Committee under the Bonus Plan in effect at the time. Any such bonus shall be subject to (i) except as provided herein, the
Executive being employed by the Company on the last day of the Company’s fiscal year or such later date as the Bonus Plan shall specify; and (ii) the Company’s Incentive Compensation Clawback Policy attached as Appendix A hereto (or
any successor policy). Any such bonus earned by Executive shall be paid no less than annually as soon as practicable (but in no event later than March 15th) after the conclusion of the Company’s fiscal year, except for any portion of the bonus
which is paid in the Company’s discretion in restricted stock units or other equity award. Bonuses relative to partial years shall be prorated. Executive may also receive special bonuses in addition to his annual bonus eligibility at the
discretion of the Board or the Committee; it being understood that there is no entitlement thereto hereunder. Any bonuses paid hereunder shall be paid, in the Company’s discretion, in cash, restricted stock units and/or other equity awards;
provided, however, that Executive’s allocation of cash, restricted stock units and other equity awards shall be the same as that of other senior executive officers for the year in question, except as may be provided under the Bonus Plan, and
not less than the greater of $300,000 or 50% shall be paid to Executive in cash. In addition, Executive will receive an annual bonus with respect to 2021 in the discretion of the Committee after the conclusion of 2021 when bonuses are paid to other
executive officers (but in no event later than March 15th). 

  
 -2- 

 Section 3.3 Equity Awards. The Company may provide
Equity Awards to Executive pursuant to, and subject to the terms and conditions of, the Company’s 2020 Stock Incentive Plan (the “2020 Plan”) (or the then current equity compensation plan of the Company, as applicable). The
Committee shall set the amount and terms of such Equity Awards. For purposes of this Agreement, “Equity Awards” includes all awards of equity granted to Executive, including but not limited to, options, restricted stock units,
restricted stock, performance shares, performance share units, and stock appreciation rights. 
 ARTICLE 4. 

EXECUTIVE BENEFITS 

Section 4.1 Vacation. Executive shall be entitled to vacation in accordance with the general policies
of the Company applicable generally to other senior executives of the Company pursuant to the Company’s personnel policies from time to time, but not less than four (4) weeks of vacation each calendar year, without reduction in
compensation. 
 Section 4.2 Benefits. Executive shall receive all other such benefits as the
Company may offer to other senior executives of the Company generally under the Company personnel plans, practices, policies and programs in effect from time to time, such as health and disability insurance coverage, paid sick leave and fully
eligible participation in deferred compensation plans. The Company shall provide Executive coverage for those benefit items made generally available to its senior level executive employees on the same terms provided to its other senior level
executive employees. Nothing contained herein shall be construed to limit the Company’s ability to amend, suspend, or terminate any employee benefit plan or policy at any time, and the right to do so is expressly reserved so long as such
amendment, suspension or termination is not particularly targeted at Executive. 
 Section 4.3
Indemnification. Executive shall have the benefit of indemnification to the fullest extent permitted by applicable law, which indemnification shall continue after the termination of this Agreement for such period as may be necessary to
continue to indemnify Executive for his acts while an officer of the Company. In addition, the Company shall cause Executive to be covered by the Company’s policies of directors and officers liability insurance in effect from time to time in
accordance with their terms, to the maximum extent of the coverage available for any director or officer of the Company, which coverage shall continue after the termination of this Agreement for such period as may be necessary to continue to cover
Executive for his acts while an officer of the Company. 
 ARTICLE 5. 

REIMBURSEMENT FOR EXPENSES 

Section 5.1 Reimbursement for Expenses. Executive shall be reimbursed by the Company for all ordinary,
necessary and reasonable expenses incurred by Executive in the performance of his duties or otherwise in furtherance of the business of the Company in accordance with the policies of the Company in effect from time to time. Executive shall endeavor
to keep accurate and complete records of all such expenses, including but not limited to, proof of payment and purpose. Executive shall account fully for all such expenses to the Company. No reimbursement will be made later than the close of the
calendar year following the calendar year in which the expense was incurred. Expenses eligible for reimbursement in any one taxable year shall not affect the amount of expenses eligible for reimbursement in any other taxable year, and the right to
expense reimbursement shall not be subject to liquidation or exchange for any other benefit. 

  
 -3- 

 ARTICLE 6. 

TERMINATION 

Section 6.1 General. The Term, and Executive’s employment hereunder, shall terminate upon the
earliest to occur of (i) Executive’s death, (ii) a termination by reason of a Disability, (iii) a termination by the Company with or without Cause, and (iv) a termination by Executive with or without Good Reason. Except as
otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of Executive’s rights to future employee benefits and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive’s
employment hereunder. 
 Section 6.2 Deemed Resignation. Upon any termination of Executive’s
employment for any reason, except as may otherwise be requested by the Company in writing and agreed upon in writing by Executive, Executive shall be deemed to have resigned from any and all directorships, committee memberships, and any other
positions Executive holds with the Company or any other member of the Company Group. 
 Section 6.3
Termination for Cause. Without limiting the generality of Section 6.5, the Company shall have the right to terminate Executive’s employment, without further obligation or liability to Executive, upon the occurrence of any one
or more of the following events, which events shall be deemed termination for cause (“Cause”). 
 6.3.1 Failure to
Perform Duties. If Executive neglects to perform the material duties of his employment under this Agreement in a professional and businesslike manner, other than due to his physical or mental infirmity, after having received thirty
(30) days written notice specifying such failure to perform and a reasonable opportunity to perform. 
 6.3.2 Willful Breach. If
Executive willfully commits a material breach of this Agreement and fails to cure such breach within thirty (30) days of written notice thereof or commits a material willful breach of his fiduciary duty to the Company. 

6.3.3 Wrongful Acts. If Executive is convicted of a felony (other than vehicular- related or a vicarious crime not based directly on
Executive’s actions) or commits fraud, material misrepresentation, embezzlement or other acts of willful material misconduct against the Company (including violating any material rules or regulations of government authorities which would
reasonably be expected to have a material adverse economic effect on the Company) that would make the continuance of his employment by the Company materially detrimental to the Company. 

Section 6.4 Termination for Death or Disability. Executive’s employment shall terminate
automatically upon Executive’s death. The Company may terminate Executive’s employment immediately upon the occurrence of a disability (“Disability”), such termination to be effective upon Executive’s receipt of
written notice of such termination. Executive will be deemed to have a “Disability” when he is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can
be expected to result in death or can be expected to last for a substantially continuous period of not less than 180 days, or begins receiving income replacement benefits for a period of not less than six months under an accident and health plan of
the Company or an affiliate by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than 6

  
 -4- 

 
months. If there should be a dispute between the Company and Executive as to Executive’s physical or mental Disability for purposes of this Agreement, the question shall be settled by the
opinion of an impartial reputable physician or psychiatrist agreed upon by the parties or their representatives and the fees of which shall be paid by the Company. The certification of such a physician or psychiatrist as to the questioned dispute
shall be final and binding upon the parties hereto.  
 Section 6.5 Termination Without
Cause. Notwithstanding anything to the contrary herein, the Company shall have the right to terminate Executive’s employment under this Agreement at any time without Cause by giving thirty (30) days written notice of such
termination to Executive. 
 Section 6.6 Termination by Executive with Good Reason. Executive may
terminate his employment under this Agreement on thirty (30) days prior notice to the Company with good reason (“Good Reason”). For purposes of this Agreement and except as otherwise agreed to by the Executive in writing,
“Good Reason” shall mean and be limited to: (i) a material breach of this Agreement by the Company (including without limitation the assignment to Executive of duties materially inconsistent with his status as General Counsel
and Secretary of the Company, or any material reduction in the authority, duties or responsibilities of Executive); or (ii) any relocation of his or its principal place of business outside the greater Las Vegas metropolitan area (without
Executive’s consent); or (iii) the requirement that Executive report to anyone other than the Chief Executive Officer; or (iv) a reduction by the Company in Executive’s then base salary or Target Bonus, a material reduction in
other benefits (except as such benefits may be changed or reduced for other senior executives), or the failure by the Company to pay Executive any material portion of his current compensation when due; or (v) following a Change in Control (as
defined in the Company’s 2020 Plan) or a reorganization or restructuring of the Company, (A) the failure of the Company, the failure of any acquiring or successor company, or, if the acquiring or successor company is a subsidiary of
another company, the failure of the highest-level parent of the acquiring or successor company, to enter into an agreement naming Executive as the General Counsel and Secretary of the highest-level parent of the acquiring or successor company with
duties materially consistent with Executive’s duties as General Counsel and Secretary of the Company, as the case may be; or (B) a requirement that Executive, as General Counsel and Secretary of the Company, the acquiring or successor
company or highest-level parent of the acquiring or successor company, must report to an executive other than the Chief Executive Officer whose authority limits Executive’s authority, duty or responsibility. For the avoidance of doubt, each of
the conditions described in clauses (i), (ii), (iii), (iv), and (v) of the preceding sentence is a separate and independent basis for termination by Executive for Good Reason. Notwithstanding the foregoing, except with respect to a termination
by Executive, Executive’s resignation shall not be treated as a resignation for Good Reason unless (a) Executive notifies the Company (including any acquiring and/or successor company) in writing of a condition constituting Good Reason
within thirty (30) days following Executive’s becoming aware of such condition; (b) the Company fails to remedy such condition within thirty (30) days following such written notice (the “Remedy Period”); and
(c) Executive resigns within thirty (30) days following the expiration of the Remedy Period. 

Section 6.7 Effect of Termination.  

6.7.1 Payment of Salary, Bonus and Expenses Upon Termination. Any termination under this Article 6 shall be effective upon receipt of
notice by Executive or the Company, as the case may be, of such termination or upon such other later date as may be provided herein or specified by the Company or Executive in the notice (the “Termination Date”), except as otherwise
provided in this Article 6. If Executive’s employment is terminated, all benefits provided to Executive by the Company hereunder shall thereupon cease, except as provided in this Section 6.7, and the Company shall pay or cause to be paid
to Executive all accrued but unpaid base salary, any unreimbursed expenses (payable pursuant to the Company’s expense reimbursement policies), any accrued vested benefits under the 

  
 -5- 

 
Company’s benefit plans including equity-based incentives and vacation (payable or provided pursuant to the terms of such benefit plans), any compensation previously voluntarily deferred by
Executive payable in accordance with the provisions of the applicable deferred compensation plan and in accordance with Executive’s election under such plan, and, except in the case of Termination for Cause, as additional severance and
notwithstanding the provisions of Section 3.2 hereof, a prorated bonus for the year of termination. Such prorated bonus shall be determined and paid as follows: (a) First, the performance criteria shall be applied to the entire year of
termination (with any subjective goals treated as satisfied at not less than target and no negative discretion otherwise applied) to determine the bonus that Executive would have received for the entire year if his employment had not terminated,
(b) Second, the amount determined under clause (a) of this sentence shall be multiplied by a fraction, the numerator of which is the number of days in the year before the date of the termination of Executive’s employment and the
denominator of which is three hundred sixty five (365), to determine the amount of the prorated bonus, and (c) Third, the prorated bonus shall be paid at the times and in the form specified when the Committee determined the achievement of
performance under the Company’s bonus program for the year (provided, that, any equity-based component of the bonus shall be treated as fully vested), or, if no such time was then specified, as soon as practicable (but in no event later than
March 15th) after the end of the year in which the termination of employment occurred. If at the Termination Date, Executive shall have satisfied all the requirements to earn an annual bonus relative to the calendar year immediately preceding or
ending on the Termination Date but such bonus has not yet been paid, then except in the case of a Termination for Cause, such bonus shall be paid to Executive at the same time such bonus was otherwise scheduled to have been paid. In addition,
promptly upon submission by Executive of his unpaid expenses incurred prior to the Termination Date and owing to Executive pursuant to Article 5, reimbursement for such expenses shall be made. If Executive’s employment is terminated for
“Cause,” or by the Executive without “Good Reason”, Executive shall not be entitled to receive any payments other than as specified in this Section 6.7.1. Termination by the Company for Cause shall be in addition to and
without prejudice to any other right or remedy that the Company may be entitled to at law, in equity, or under this Agreement. 
 6.7.2
Termination Without Cause or Termination by Executive with Good Reason Other than in Connection with a Change in Control. If the Company terminates Executive’s employment without Cause or Executive terminates his employment with
Good Reason (other than in connection with a Change in Control as contemplated by Section 6.7.4), the following shall apply: 
  

	 	(a)	 Executive shall be entitled to receive an amount equal to one hundred percent (100%) times
(i) Executive’s annual base salary (such multiple of such annual base salary, the “Base Severance Benefit”) in effect on the date of termination; plus (ii) the total dollar value of the target bonus, the
“Bonus Amount”). The Base Severance Benefit and Bonus Amount shall be paid to Executive in a lump sum on the first payroll date following the release becoming effective and revocation rights thereon having lapsed, except as
otherwise provided in Section 6.10.4 or Section 6.10.5 below, as applicable. In addition, Executive shall be entitled to receive any amounts payable under Section 6.7.1 above. The payments contemplated herein shall not be subject to
any duty of mitigation by Executive nor to offset for any income earned by Executive following termination. 

  

	 	(b)	 Executive shall also be entitled to receive health benefits coverage for Executive and his dependents, and
disability insurance coverage for Executive, under the same plan(s) or arrangement(s) under which Executive and his dependents were covered immediately before his termination of employment or plan(s) established or arrangement(s) provided by the
Company or any of its Subsidiaries thereafter for the benefit of senior executives until the earliest of (i) eighteen (18) months; and (ii) the date Executive (and in the case of his dependents, the dependents)

  
 -6- 

	 	
becomes covered or eligible for coverage under any other group health plan or group disability plan (as the case may be) not maintained by the Company Group; provided, however, that if such other
group health plan excludes any preexisting condition that Executive or Executive’s dependents may have when coverage under this Section 6.7.2 shall continue (but not beyond the period described in clause (i) of this sentence) with
respect to such pre-existing condition until such exclusion under such other group health plan lapses or expires. The Company shall pay any applicable premiums on such insurance coverage; provided, however,
that if at any time the Company determines that its payment of such premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of the Internal Revenue Code of 1986, as amended (the “Code”) or any
other Code section, law or regulation of similar effect (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of paying such premiums,
the Company will instead pay to Executive a fully taxable monthly cash payment in an amount such that, after payment by Executive of all taxes on such payment, Executive retains an amount equal to the premiums the Company would have paid for such
month, with such monthly payment being made on the last day of each month for the remainder of the eighteen (18) month period. In the event Executive is required to make an election under Sections 601 through 607 of the Employee Retirement
Income Security Act of 1974, as amended (commonly known as COBRA) to qualify for the benefits described in this Section 6.7.2, the obligations of the Company and its Subsidiaries under this Section 6.7.2 shall be conditioned upon
Executive’s timely making such an election. Nothing contained herein shall prevent Executive or his dependents from securing continued coverage under COBRA at their own expense to the extent permitted by COBRA or otherwise applicable law. Any
payment or reimbursement of benefits under this Section 6.7.2 that is taxable to Executive or his dependents shall be made by December 31 of the calendar year following the calendar year in which Executive or his dependent incurred the
expense. Expenses eligible for reimbursement in any one taxable year shall not affect the amount of expenses eligible for reimbursement in any other taxable year, and the right to expense reimbursement shall not be subject to liquidation or exchange
for any other benefit. The benefits described in this Section 6.7.2(b) shall be referred to as the “Health and Disability Coverage Continuation”. 

 

	 	(c)	 Notwithstanding anything contained in the 2020 Plan or any Equity Award agreement under the 2020 Plan to the
contrary, the following provisions shall apply to the Executive’s Equity Awards: 

  

	 	(i)	 With respect to any Equity Awards that are subject to vesting in the ordinary course based solely upon the
provision of continued service (“Time Vested Awards”), all such Time Vested Awards that vest over the period of time following termination until the end of the following calendar year following the termination date shall vest in
full as of the date of such termination. 

  
 -7- 

	 	(ii)	 With respect to any Equity Awards that are subject to vesting in the ordinary course based upon the achievement
of performance conditions (and whether or not exists any service vesting condition) (“Performance Vested Awards”), such Performance Vested Awards will vest as of the date of such termination based on (A) actual achievement of
performance conditions, with respect to any applicable performance period that has completed on or prior to the date of such termination, and (B) the actual achievement of performance conditions (which will be determined by the Compensation
Committee upon completion of the performance period), with respect to any applicable performance period that has not been completed on or prior to the date of such termination, subject to proration based upon the number of whole days Executive has
been employed during any applicable performance period. 

 6.7.3 Termination for Death or Disability. If Executive
dies or the Company terminates Executive’s employment due to Disability, the following shall apply: 
  

	 	(a)	 Executive (or his estate) shall be entitled to receive any amounts payable under Section 6.7.1 above.

  

	 	(b)	 Executive (and/or his eligible dependents) shall also be entitled to receive the Health and Disability Coverage
Continuation. 

  

	 	(c)	 Notwithstanding anything contained in the 2020 Plan or any Equity Award agreement under the 2020 Plan to the
contrary, the following provisions shall apply to the Executive’s Equity Awards (the “Termination Equity Treatment”) and shall apply to Executive (or his estate): 

 

	 	(i)	 All Time Vested Awards shall vest in full as of the date of such termination. 

 

	 	(ii)	 Performance Vested Awards will vest as of the date of such termination based on (A) actual achievement of
performance conditions, with respect to any applicable performance period that has completed on or prior to the date of such termination, and (B) the greater of actual or target achievement of performance conditions, with respect to any
applicable performance period that has not been completed on or prior to the date of such termination. 

 6.7.4
Termination Without Cause or Termination by Executive with Good Reason Prior to, On or Within Twenty-Four (24) Months After a Change in Control. If the Company terminates Executive’s employment without Cause or
Executive terminates his employment with Good Reason within ninety (90) days prior to, on or within twenty-four (24) months after a Change in Control, the following shall apply: 

 

	 	(a)	 Executive shall be entitled to receive any amounts payable under Section 6.7.1 above.

  

	 	(b)	 The Company shall pay to Executive in lieu of the Base Severance Benefit and the Bonus Amount, in a lump sum on
the first payroll date following the release becoming effective (and revocation rights thereon having lapsed), except as otherwise provided in Section 6.10.4 or Section 6.10.5 below, as applicable, an amount equal to two hundred percent
(200%) of the sum of Executive’s annual base salary in effect on the date of termination and the Target Bonus for the year of termination. 

  
 -8- 

	 	(c)	 Executive shall be entitled to receive the Health and Disability Coverage Continuation. 

 

	 	(d)	 Executive shall be entitled to the Termination Equity Treatment. 

6.7.5 I.R.C. Section 409A. 
  

	 	(a)	 The compensation arrangements under this Agreement are intended to comply with, or be exempt from,
Section 409A of the Code, and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”), and will be interpreted in a manner intended to comply with, or be exempt from, Code
Section 409A. If any payment of money or other benefits due to the Executive hereunder could cause the application of an accelerated or additional tax under Code Section 409A (a “409A Tax”), the Company and Executive shall
cooperate in good faith to modify this Agreement to the extent possible, in a manner, that does not cause such 409A Tax while endeavoring to maintain the economic benefits hereunder; provided, however, neither the Company, nor its respective
officers, employees and/or representatives, shall have any liability to the Executive with respect to any such determination, or any such taxes, interest or penalties, or liability for any other alleged damages related thereto.

  

	 	(b)	 In the event that any compensation with respect to Executive’s separation from service is “deferred
compensation” within the meaning of Code Section 409A, the stock of the Company or any affiliate is publicly traded on an established securities market or otherwise, and Executive is determined to be a “specified employee,” as
defined in Section 409A(a)(2)(B)(i) of the Code, payment of such compensation shall be delayed as required by Code Section 409A. Such delay shall last six months from the date of Executive’s separation from service, except in the
event of Executive’s death. Within thirty (30) days following the end of such six-month period, or, if earlier, Executive’s death, the Company will make a
catch-up payment to Executive equal to the total amount of such payments that would have been made during the six-month period but for this Section 6.7.5. Whenever
payments under this Agreement are to be made in installments, each such installment shall be deemed to be a separate payment for purposes of Section 409A. Payments of compensation or benefits on Executive’s termination of employment (other
than accrued salary and other accrued amounts that must be paid under applicable law, and “welfare benefits” specified in Treasury Regulations Section 1.409A-1(a)(5)) shall be paid only if and
when the termination of employment constitutes a “separation from service” under Treasury Regulation Section 1.409A-1(h). 

6.7.6 Suspension. In lieu of terminating Executive’s employment hereunder for Cause under Section 6.3, the Company shall have
the right, at its sole election, to suspend the performance of duties by Executive under this Agreement during the continuance of events or circumstances under Section 6.3 for an aggregate of not more than thirty (30) days during the Term
(the “Default Period”) by giving Executive written notice of the Company’s election to do so at any time during the Default Period. The Company’s exercise of its right to suspend the operation of this Agreement shall not
preclude the Company from subsequently terminating Executive’s employment hereunder; provided nothing herein 

  
 -9- 

 
shall eliminate the Company’s obligation to provide required written notice, or prevent Executive from having the opportunity to cure any defect raised in such notice, to the extent
applicable under the relevant subsection of Section 6.3. Executive shall not render services to any other person, firm or corporation in the mining business during any period of suspension. Executive shall be entitled to continued compensation
and benefits pursuant to the provisions of this Agreement during the Default Period. 
 Section 6.8 No-Exclusivity of Rights. Nothing in this Agreement shall prevent or limit Executive’s continuing or future participation in any plan, program, policy or practice provided by the Company or its
subsidiaries and for which the Executive may qualify, nor shall anything herein limit or otherwise affect such rights as Executive may have under any other contract or agreement with the Company or its subsidiaries at or subsequent to the
Termination Date (“Other Benefits”), which such Other Benefits shall be payable in accordance with such plan, policy, practice or program or contract or agreement, except as explicitly modified by this Agreement. Notwithstanding the
foregoing, if Executive receives payments and benefits pursuant to Article 6 of this Agreement, Executive shall not be entitled to any severance pay or benefits under any severance plan, program or policy of the Company and its subsidiaries, unless
otherwise specifically provided therein in a specific reference in or to this Agreement. 
 Section 6.9 Full
Settlement. Except as expressly provided for herein, in no event shall Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to Executive under any of the provisions of this
Agreement and such amounts shall not be reduced whether or not Executive obtains other employment. 
 Section 6.10
Release. Notwithstanding anything contained herein to the contrary, it shall be a condition for Executive’s right to receive any severance benefits hereunder that he execute a general release in favor of the Company and its
affiliates in the form as may be reasonably requested by the Company and agreed to by the Executive (provided, that, the Executive shall not be obligated to agree to additional matters beyond the release itself), which release shall not encompass
the payments contemplated hereby or other individual compensatory agreements with the Company, rights as a stockholder of the Company, or rights to indemnification or coverage under directors’ and officers’ liability insurance or for
unpaid compensation); provided, however that the requirement that Executive (or Executive’s estate) execute such a general release shall not apply in the event of a termination due to death under Section 6.4 (Termination for Death or
Disability) hereof. The timing of payments under this Agreement upon the execution of the general release shall be governed by the following provisions: 

6.10.1 The Company must deliver the release to Executive for execution no later than fourteen (14) days after Executive’s
termination of employment. If the Company fails to deliver the release to Executive within such fourteen (14) day period, Executive will be deemed to have satisfied the release requirement and will receive payments conditioned on execution of
the release as though Executive had executed the release and all revocation rights had lapsed at the end of such 14 day period. 
 6.10.2
Executive must execute the release within forty-five (45) days from its delivery to him. 
 6.10.3 If Executive has revocation rights,
Executive shall exercise such rights, if at all, not later than seven (7) days after executing the release. 
 6.10.4 In any case in
which the release (and the expiration of any revocation rights) could only become effective in a particular tax year of Executive, payments that are subject to Code Section 409A and are conditioned on execution of the release shall begin within
twenty (20) days after the release becomes effective and revocation rights have lapsed. 

  
 -10- 

 6.10.5 In any case in which the release (and the expiration of any revocation rights) could
become effective in one of two taxable years of Executive depending on when Executive executes the release, payments that are subject to Code Section 409A and are conditioned on execution of the release shall not begin before the first business
day of the later of such tax years. 
 Section 6.11 Excise Tax Limitation. 

6.11.1 Notwithstanding anything contained in this Agreement to the contrary, (i) in the event that any payment or benefit (within the
meaning of Section 280G(b)(2) of the Code) to be paid or made payable to Executive or for Executive’s benefit pursuant to the terms of this Agreement or otherwise in connection with, or arising out of, Executive’s employment with the
Company or any of its Subsidiaries on a “change of control” within the meaning of Section 280G of the Code (a “Payment” or “Payments”) would be subject to the excise tax imposed by Section 4999
of the Code (the “Excise Tax”), and (ii) (A) the net amount of the Payments Executive would retain after payment of the Excise Tax and federal, state and local income taxes on the Payments would be less than (B) the net
amount of the Payments Executive would retain, after payment of the Excise Tax and federal, state and local income taxes on the Payments, if the Payments were reduced to the extent necessary that no portion of the Payments would be subject to the
Excise Tax (the “Section 4999 Limit”), then the Payments shall be reduced (but not below zero) to the Section 4999 Limit. If a reduction in the Payments is necessary so that the Payments do not exceed the
Section 4999 Limit and none of the Payments constitute non-qualified deferred compensation (within the meaning of Section 409A of the Code), then the reduction shall occur in the manner Executive
elects in writing prior to the date of payment. Any notice given by Executive pursuant to the preceding sentence shall take precedence over the provisions of any other agreement, plan or arrangement governing Executive’s rights and entitlements
to any benefits or compensation. If any Payment constitutes non-qualified deferred compensation or if Executive fails to elect an order, then the Payments to be reduced will be determined in a manner which has
the least economic cost to Executive and, to the extent the economic cost is equivalent, will be reduced in the inverse order of when payment would have been made to Executive, until the reduction is achieved. For purposes of the calculations
described above, it shall be assumed that Executive’s tax rate will be the maximum marginal federal and applicable state income tax rate on earned income (taking into account the deductibility of any state taxes for purposes of calculating any
federal taxes). 
 6.11.2 All determinations required to be made under this Section 6.11 (each, a “Determination”)
shall be made, at the Company’s expense, by the accounting firm which is the Company’s accounting firm prior to a “change of control” (within the meaning of Section 280G of the Code) or another nationally recognized
accounting firm designated by the Board (or a committee thereof) prior to the change of control (the “Accounting Firm”). The Accounting Firm shall provide its calculations, together with detailed supporting documentation, both to
the Company and to Executive before payment of Executive’s Severance Payment hereunder (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive (in either case provided that the Company
or Executive believes in good faith that any of the Payments may be subject to the Excise Tax). Within ten (10) calendar days of the delivery of the Determination to Executive, Executive shall have the right to dispute the Determination (the
“Dispute”). The existence of any Dispute shall not in any way affect Executive’s right to receive the Payments in accordance with the Determination. If there is no Dispute, the Determination by the Accounting Firm shall be
final, binding and conclusive upon the Company and Executive, subject to the application of Section 6.11.3. 
 6.11.3 As a result of
the uncertainty in the application of Sections 4999 and 280G of the Code, it is possible that the Payments either will have been made or will not have been made by the Company, in either case in a manner inconsistent with the limitations provided in
Section 6.11.1 (an “Excess Payment” or “Underpayment”, respectively). If it is established pursuant to (a) a final 

  
 -11- 

 
determination of a court for which all appeals have been taken and finally resolved or the time for all appeals has expired, or (b) an Internal Revenue Service (the “IRS”)
proceeding which has been finally and conclusively resolved, that an Excess Payment has been made, such Excess Payment shall be deemed for all purposes to be a loan to Executive made on the date Executive received the Excess Payment and Executive
shall repay the Excess Payment to the Company on demand, together with interest on the Excess Payment at one hundred twenty percent (120%) of the applicable federal rate (as defined in Section 1274(d) of the Code) compounded semi-annually from
the date of Executive’s receipt of such Excess Payment until the date of such repayment. If it is determined (i) by the Accounting Firm, the Company (which shall include the position taken by the Company, together with its consolidated
group, on its federal income tax return) or the IRS, (ii) pursuant to a determination by a court, or (iii) upon the resolution to Executive’s satisfaction of the Dispute, that an Underpayment has occurred, the Company shall pay an
amount equal to the Underpayment to Executive within ten (10) calendar days of such determination or resolution, together with interest on such amount at one hundred twenty percent (120%) of the applicable federal rate compounded semi-annually
from the date such amount should have been paid to Executive pursuant to the terms of this Agreement or otherwise, but for the operation of this Section 6.11.3, until the date of payment. 

ARTICLE 7. 
 RESTRICTIVE
COVENANTS 
 Section 7.1 General. Executive acknowledges and recognizes the highly competitive
nature of the business of the Company Group, that access to Confidential Information renders Executive special and unique within the industry of the Company Group, and that Executive will have the opportunity to develop substantial relationships
with existing and prospective clients, accounts, customers, consultants, contractors, investors, and strategic partners of the Company Group during the course of and as a result of Executive’s employment with the Company. In light of the
foregoing, as a condition of Executive’s employment by the Company, and in consideration of Executive’s employment hereunder and the compensation and benefits provided herein, Executive acknowledges and agrees to the covenants contained in
this Article 7. Executive further recognizes and acknowledges that the restrictions and limitations set forth in this Article 7 are reasonable and valid in geographical and temporal scope and in all other respects and are essential to protect the
value of the business and assets of the Company Group. 
 Section 7.2 Confidential Information. 

7.2.1 Executive acknowledges that, during the Term, Executive will have access to information about the Company Group and that
Executive’s employment with the Company shall bring Executive into close contact with confidential and proprietary information of the Company Group. In recognition of the foregoing, Executive agrees, at all times during the Term and thereafter,
to hold in confidence, and not to use, except for the benefit of the Company Group, or to disclose to any Person without written authorization of the Company, any Confidential Information; provided, that nothing in this Section 7.2 shall
prevent Executive from disclosing Confidential Information as may be required by applicable law, rule or court order or governmental or regulatory investigation, or as otherwise reasonably appropriate pursuant to any legal process between Executive
and any member of the Company Group. 
 For purposes of this Agreement: 

“Confidential Information” means confidential, proprietary or trade secret information that the Company Group has or will
develop, acquire, create, compile, discover, or own, that has value in or to the business of the Company Group that is not generally known and that the Company wishes to 

  
 -12- 

 
maintain as confidential. Confidential Information includes, but is not limited to, any and all non-public information that relates to the actual or
anticipated business and/or products, research, or development of the Company Group, or to the Company Group’s technical data, trade secrets, or know-how, including, but not limited to, research, plans,
or other information regarding the Company Group’s products or services and markets, customer lists, and customers (including, but not limited to, customers of the Company on whom Executive called or with whom Executive may become acquainted
during the Term), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company either directly
or indirectly in writing, orally, or by drawings or inspection of premises, parts, equipment, or other Company Group property. Notwithstanding the foregoing, Confidential Information shall not include any of the foregoing items (i) that have
become publicly and widely known or are otherwise known within the industry of the Company Group through no unauthorized disclosure by Executive or others who were under confidentiality obligations as to the item or items involved, (ii) that
have been independently developed without the use of or reference to Confidential Information or (iii) if such item has been provided by a third party to Executive and is not known by Executive to be subject to any confidentiality restrictions.

 7.2.2 Nothing in this Agreement shall prohibit or impede Executive from communicating, cooperating or filing a complaint with any U.S.
federal, state or local governmental or law enforcement branch, agency or entity (collectively, a “Governmental Entity”) with respect to possible violations of any U.S. federal, state or local law or regulation, or otherwise making
disclosures to any Governmental Entity, in each case, that are protected under the whistleblower provisions of any such law or regulation, provided that in each case such communications and disclosures are consistent with applicable law. Executive
understands and acknowledges that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (i) in confidence to a federal, state, or local
government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
Executive understands and acknowledges further that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret
information in the court proceeding, if the individual files any document containing the trade secret under seal; and does not disclose the trade secret, except pursuant to court order. Moreover, Executive is not required to give prior notice to (or
get prior authorization from) the Company regarding any such communication or disclosure. Notwithstanding the foregoing, under no circumstance will Executive be authorized to disclose any information covered by attorney-client privilege or attorney
work product of any member of the Company Group without prior written consent of Company’s General Counsel or other officer designated by the Company. Participant does not need the prior authorization of (or to give notice to) any member of the
Company Group regarding any communication, disclosure, or activity permitted by this paragraph. 
 Section 7.3
Assignment of Intellectual Property Rights. (a) Executive agrees that he will, without additional compensation, promptly make full written disclosure to the Company, and will hold in trust for the sole right and benefit of the
Company all developments, original works of authorship, inventions, concepts, know-how, improvements, trade secrets, and similar proprietary rights, whether or not patentable or registrable under copyright or
similar laws, which Executive may (or have previously) solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the Term, whether or not during regular working hours, provided
they arise out of Executive’s employment with the Company or are developed through the use of equipment, supplies, or facilities of any member of the Company Group, or any Confidential Information (collectively referred to as
“Developments”). Executive further acknowledges that all Developments made by Executive (solely or jointly with others) within the scope of and during the Term are “works 

  
 -13- 

 
made for hire” (to the greatest extent permitted by applicable law) for which Executive is compensated by the Company, unless regulated otherwise by law, but that, in the event any such
Development is deemed not to be a work made for hire, Executive hereby assigns to the Company, or its designee, all Executive’s right, title, and interest throughout the world in and to any such Development. 

(b) Executive agrees to reasonably assist the Company, or its designee, at the Company’s expense, in every reasonable way to secure the
rights of the Company Group in the Developments and any copyrights, patents, trademarks, service marks, database rights, domain names, mask work rights, moral rights, and other intellectual property rights relating thereto in any and all countries,
including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments, recordations, and all other instruments that the Company shall deem necessary
in order to apply for, obtain, maintain, and transfer such rights and in order to assign and convey to the Company Group the sole and exclusive right, title, and interest in and to such Developments, and any intellectual property and other
proprietary rights relating thereto. Executive further agrees that Executive’s obligation to execute or cause to be executed, when it is in Executive’s power to do so, any such instrument or papers shall continue after the termination of
the Term until the expiration of the last such intellectual property right to expire in any country of the world; provided, however, that the Company shall reimburse Executive for Executive’s reasonable expenses incurred in connection with
carrying out the foregoing obligation. If the Company is unable because of Executive’s mental or physical incapacity or unavailability for any other reason to secure Executive’s signature to apply for or to pursue any application for any
United States or foreign patents or copyright registrations covering Developments or original works of authorship assigned to the Company as above, then Executive hereby irrevocably designates and appoints the Company and its duly authorized
officers and agents as Executive’s agent and attorney in fact to act for and in Executive’s behalf and stead to execute and file any such applications or records and to do all other lawfully permitted acts to further the application for,
prosecution, issuance, maintenance, and transfer of letters patent or registrations thereon with the same legal force and effect as if originally executed by me. Executive hereby waives and irrevocably quitclaims to the Company any and all claims,
of any nature whatsoever, that Executive now or hereafter have for past, present, or future infringement of any and all proprietary rights assigned to the Company. 

Section 7.4 Non-Competition. During the Term and the
Post-Termination Restricted Period, Executive shall not, anywhere within the Territory or for the benefit of a Competing Business’s operations or sales within the Territory, directly or indirectly, acting individually or as an owner,
shareholder, partner, employee, contractor, agent or otherwise (other than on behalf of the Company): (a) provide services that are the same as or similar in function or purpose to the services Executive provided to the Company during the last
twelve (12) months of employment or such shorter period of time as Executive has been employed (the “Look Back Period”); or (b) provide services that are otherwise likely or probable to result in the use or disclosure of
Confidential Information, in each case of (a) or (b) to a Competing Business. Notwithstanding the foregoing, Executive may at any time own, for investment purposes only, up to ten percent (10%) of the equity of (i) any publicly-held
company whose equity is either listed on a national stock exchange or on the NASDAQ National Market System or (ii) any non-publicly-held company in a passive investment. Executive shall be permitted to
provide services to a unit, division, or subsidiary of entity engaging in a Competing Business if such unit, division or subsidiary is not engaging in the Competing Business and Executive is not providing services to any unit, division or subsidiary
engaging in the Competing Business. The Post-Termination Restriction Period shall not apply under this Section 7.4 if Executive’s employment is terminated by the Company without Cause or by Executive with Good Reason. 

  
 -14- 

 For purposes of this Agreement: 

“Competing Business” shall mean any person, firm, corporation, partnership or business that engages in any business, directly
or indirectly (through a subsidiary or otherwise) which competes with the Company Group’s business activities related to rare earth mining and processing. 

“Post-Termination Restricted Period” shall mean the period commencing on the date of the termination of the Term for any
reason and ending on the twelve (12) month anniversary of such date of termination. 
 “Territory” shall mean within a
180-mile radius of Mountain Pass, California or within 180-mile radius of any jurisdiction in which any member of the Company Group engages in material business, derives
a material portion of its revenues or has demonstrable plans to commence material business activities in. 

Section 7.5 Non-Interference. During the Term and the
Post-Termination Restricted Period, Executive shall not, directly or indirectly for Executive’s own account or for the account of any other Person, engage in Interfering Activities. For purposes of this Agreement: 

“Business Relation” shall mean any current or prospective (based upon material demonstrable activities) client, customer,
licensee, supplier, or other business relation of the Company Group, or any such relation that was a client, customer, licensee or other business relation within the prior six (6) month period, in each case, with whom Executive transacted
business or whose identity became known to Executive in connection with Executive’s employment hereunder. 
 “Interfering
Activities” shall mean (A) recruiting, encouraging, soliciting, or inducing, or in any manner attempting to recruit, encourage, solicit, or induce, any Person employed by, or providing consulting services to, any member of the Company
Group to terminate such Person’s employment or services (or in the case of a consultant, materially reducing such services) with the Company Group in order to engage in a Competing Business, (B) hiring any individual who was employed by
the Company Group within the 90 day period prior to the date of such hiring (but not including anyone whose employment was terminated (or constructively terminated) by the Company Group), or (C) encouraging, soliciting, or inducing, or
in any manner attempting to encourage, solicit, or induce, any Business Relation to cease doing business with or reduce the amount of business conducted with the Company Group, or in any way interfering with the relationship between any such
Business Relation and the Company Group; provided, that engaging in a general solicitation not specifically targeted at the foregoing individuals or providing a personal reference shall not be Interfering Activities. 

Section 7.6 Return of Documents. In the event of Executive’s termination of employment hereunder
for any reason, Executive shall deliver to the Company (and will not keep in Executive’s possession, recreate, or deliver to anyone else) or destroy, at Executive’s sole option, any and all Confidential Information and all other documents,
materials, information, and property otherwise belonging to the Company Group; provided, that Executive shall be entitled to retain his personal contacts, calendars, digital or physical rolodex, personal correspondence, information reasonably needed
for Executive’s personal tax return preparation and/or any other personal property he may keep in his office. Executive may retain his mobile phone and number and any electronic equipment used by him at his residences. 

Section 7.7 Independence; Severability; Blue Pencil. Each of the rights enumerated in this Article 7
shall be independent of the others and shall be in addition to and not in lieu of any other rights and remedies available to the Company Group at law or in equity. If any of the provisions of this Article 7 or any part of any of them is hereafter
construed or adjudicated to be invalid or unenforceable, the same shall not affect the remainder of this Article 7, which shall be given full effect without regard to 

  
 -15- 

 
the invalid portions. If any of the covenants contained herein are held to be invalid or unenforceable because of the duration of such provisions or the area or scope covered thereby, each of the
Company and Executive agree that the court making such determination shall have the power to reduce the duration, scope, and/or area of such provision to the maximum and/or broadest duration, scope, and/or area permissible by law, and in its reduced
form said provision shall then be enforceable. 
 Section 7.8 Injunctive Relief. Executive expressly
acknowledges that any breach or threatened breach of any of the terms and/or conditions set forth in this Article 7 may result in substantial, continuing, and irreparable injury to the members of the Company Group. Therefore, Executive hereby
agrees that, in addition to any other remedy that may be available to the Company, any member of the Company Group shall be entitled to seek injunctive relief, specific performance, or other equitable relief by a court of appropriate jurisdiction in
the event of any breach or threatened breach of the terms of this Article 7. Notwithstanding any other provision to the contrary, Executive acknowledges and agrees that the Post-Termination Restricted Period shall be tolled during any period of
violation of any of the covenants in this Article 7 (so long as the Company Group takes steps to attempt to cause Executive to cease such violation once aware of it) and during any other period required for litigation during which the Company or any
other member of the Company Group seeks to enforce such covenants against Executive if it is ultimately determined that Executive was in breach of such covenants. 

Section 7.9 Disclosure of Covenants. As long as it remains in effect, Executive will disclose the
existence of the covenants contained in this Article 7 to any prospective employer, partner, co-venturer, investor, or lender prior to entering into an employment, partnership, or other business relationship with such Person or entity.

 Section 7.10 Other Covenants. Notwithstanding anything contained in this Agreement to the
contrary, in the event that Executive is subject to similar restrictive covenants pursuant to any other agreement with the Company or any other member of the Company Group (“Other Covenants”), the covenants contained in this
Agreement shall be in addition to, and not in lieu of, any such Other Covenants, and enforcement by the Company of the covenants contained in this Agreement shall not preclude the Company or any other applicable member of the Company Group from
enforcing such Other Covenants in accordance with their terms; provided, that, all Other Covenants in effect as of the date hereof shall be superseded by the covenants contained in this Agreement and be of no further force or effect. 

ARTICLE 8. 
 ARBITRATION

 Section 8.1 General. Except for a claim for injunctive relief under Section 7.8, any
controversy, dispute, or claim between the parties to this Agreement, including any claim arising out of, in connection with, or in relation to the formation, interpretation, performance or breach of this Agreement shall be settled exclusively by
arbitration, before a single arbitrator who is a retired judge, in accordance with this Article 8 and the then most applicable rules of JAMS. Judgment upon any award rendered by the arbitrator may be entered by any state or federal court having
jurisdiction thereof. Such arbitration shall be administered by JAMS and the costs thereof borne by the Company. Arbitration shall be the exclusive remedy for determining any such dispute, regardless of its nature. Notwithstanding the foregoing,
either party may in an appropriate matter apply to a court for provisional relief, including a temporary restraining order or a preliminary injunction, on the ground that the award to which the applicant may be entitled in arbitration may be
rendered ineffectual without provisional relief. Unless mutually agreed by the parties otherwise, any arbitration shall take place in Las Vegas, Nevada. 

  
 -16- 

 Section 8.2 Selection of Arbitrator. In the event
the parties are unable to agree upon an arbitrator, the parties shall select a single arbitrator from a list of nine arbitrators drawn by the parties at random from the “Independent” (or “Gold Card”) list of retired judges or, at
the option of Executive, from a list of nine persons (which shall be retired judges or corporate or litigation attorneys experienced in executive employment agreements) provided by the office of JAMS having jurisdiction over Las Vegas, Nevada. If
the parties are unable to agree upon an arbitrator from the list so drawn, then the parties shall each strike names alternately from the list, with the first to strike being determined by lot. After each party has used four strikes, the remaining
name on the list shall be the arbitrator. If such person is unable to serve for any reason, the parties shall repeat this process until an arbitrator is selected. 

Section 8.3 Applicability of Arbitration; Remedial Authority. This agreement to resolve any disputes
by binding arbitration shall extend to claims related to the employment relationship set forth herein against any parent, subsidiary or affiliate of each party, and, when acting within such capacity, any officer, director, stockholder, employee or
agent of each party, or of any of the above, and shall apply as well to claims arising out of state and federal statutes and local ordinances as well as to claims arising under the common law. In the event of a dispute subject to this paragraph the
parties shall be entitled to reasonable discovery subject to the discretion of the arbitrator. The remedial authority of the arbitrator (which shall include the right to grant injunctive or other equitable relief) shall be the same as, but no
greater than, would be the remedial power of a court having jurisdiction over the parties and their dispute. The arbitrator shall, upon an appropriate motion, dismiss any claim without an evidentiary hearing if the party bringing the motion
establishes that he or it would be entitled to summary judgment if the matter had been pursued in court litigation. In the event of a conflict between the applicable rules of JAMS and these procedures, the provisions of these procedures shall
govern. 
 Section 8.4 Fees and Costs. Any filing or administrative fees shall be borne initially by
the party requesting arbitration. The Company shall be responsible for the costs and fees of the arbitration. Notwithstanding the foregoing, if Executive prevails on a material issue in any arbitration or in any enforcement or other court
proceedings, Executive shall be entitled to reimbursement from the Company for all of Executive’s costs (including but not limited to the arbitrator’s compensation), expenses, and attorneys’ fees. 

Section 8.5 Award Final and Binding. The arbitrator shall render an award and written opinion, and the
award shall be final and binding upon the parties. If any of the provisions of this paragraph, or of this Agreement, are determined to be unlawful or otherwise unenforceable, in whole or in part, such determination shall not affect the validity of
the remainder of this Agreement, and this Agreement shall be reformed to the extent necessary to carry out its provisions to the greatest extent possible and to insure that the resolution of all conflicts between the parties, including those arising
out of statutory claims, shall be resolved by neutral, binding arbitration. If a court should find that the arbitration provisions of this Agreement are not absolutely binding, then the parties intend any arbitration decision and award to be fully
admissible in evidence in any subsequent action, given great weight by any finder of fact, and treated as determinative to the maximum extent permitted by law. 

ARTICLE 9. 

MISCELLANEOUS 

Section 9.1 Amendments. The provisions of this Agreement may not be waived, altered, amended or
repealed in whole or in part except by the signed written consent of the parties sought to be bound by such waiver, alteration, amendment or repeal. 

  
 -17- 

 Section 9.2 Clawbacks. The payments to
Executive pursuant to this Agreement or otherwise are subject to forfeiture or recovery or other action by the Company pursuant to the Company’s Incentive Compensation Clawback Policy attached as Appendix A hereto (or any successor incentive
compensation clawback policy generally applicable to senior executive officers of the Company), or that it may be required to adopt under the Dodd-Frank Wall Street Reform and Consumer Protection Act and implementing rules and regulations
thereunder, or as otherwise required by law. 
 Section 9.3 Entire Agreement. This Agreement
constitutes the total and complete agreement of the parties and supersedes all prior and contemporaneous understandings and agreements heretofore made, including the Current Agreement which is hereby terminated, and there are no other
representations, understandings or agreements. 
 Section 9.4 Counterparts. This Agreement may be
executed in one of more counterparts, each of which shall be deemed and original, but all of which shall together constitute one and the same instrument. 

Section 9.5 Severability. Each term, covenant, condition or provision of this Agreement shall be
viewed as separate and distinct, and in the event that any such term, covenant, condition or provision shall be deemed by an arbitrator or a court of competent jurisdiction to be invalid or unenforceable, the court or arbitrator finding such
invalidity or unenforceability shall modify or reform this Agreement to give as much effect as possible to the terms and provisions of this Agreement. Any term or provision which cannot be so modified or reformed shall be deleted and the remaining
terms and provisions shall continue in full force and effect. 
 Section 9.6 Waiver or
Delay. The failure or delay on the part of the Company, or Executive to exercise any right or remedy, power or privilege hereunder shall not operate as a waiver thereof A waiver, to be effective, must be in writing and signed by the party
making the waiver. A written waiver of default shall not operate as a waiver of any other default or of the same type of default on a future occasion. 

Section 9.7 Successors and Assigns. This Agreement shall be binding on and shall inure to the benefit
of the parties to it and their respective heirs, legal representatives, successors and assigns, except as otherwise provided herein. Except as provided in this Section 9.7, without the prior written consent of Executive, this Agreement shall
not be assignable by the Company. The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and
agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. “Company” means the Company as hereinbefore defined and any successor
to its business and/or assets as aforesaid that assumes and agrees to perform this Agreement by operation of law or otherwise. 

Section 9.8 No Assignment or Transfer by Executive. Neither this Agreement nor any of the rights,
benefits, obligations or duties hereunder may be assigned or transferred by Executive other than to Executive’s estate or beneficiaries in the event amounts payable to Executive hereunder remain due after Executive’s death. Any purported
assignment or transfer by Executive shall be void. 
 Section 9.9 Necessary Acts. Each party to this
Agreement shall perform any further acts and execute and deliver any additional agreements, assignments or documents that may be reasonably necessary to carry out the provisions or to effectuate the purpose of this Agreement. 

  
 -18- 

 Section 9.10 Governing Law. This Agreement and all
subsequent agreements between the parties shall be governed by and interpreted, construed and enforced in accordance with the laws of the State of Nevada. 

Section 9.11 Notices. All notices, requests, demands and other communications to be given under this
Agreement shall be in writing and shall be deemed to have been duly given on the date of service, if personally served on the party to whom notice is to be given, or 48 hours after mailing, if mailed to the party to whom notice is to be given by
certified or registered mail, return receipt requested, postage prepaid, and properly addressed to the party at his address set forth as follows or any other address that any party may designate by written notice to the other parties: 

 

			
	 To Executive:
	  	 Elliot D. Hoops
 At the address in the
Company’s records

		
	 To the Company:
	  	 MP Materials, Corp.
 6720 Via Austi Parkway
Suite 450
 Las Vegas, Nevada 89119
 Attn: General Counsel

Telephone: 702 844-6111

 Section 9.12 Headings and Captions. The headings and captions used
herein are solely for the purpose of reference only and are not to be considered as construing or interpreting the provisions of this Agreement. 

Section 9.13 Construction. All terms and definitions contained herein shall be construed in such a
manner that shall give effect to the fullest extent possible to the express or implied intent of the parties hereby. 

Section 9.14 Counsel. Executive has been advised by the Company that he should consider seeking the
advice of counsel in connection with the execution of this Agreement and Executive has had an opportunity to do so. Executive has read and understands this Agreement, and has sought the advice of counsel to the extent he has determined appropriate.

 Section 9.15 Withholding of Compensation. Executive hereby agrees that the Company may deduct and
withhold from the compensation or other amounts payable to Executive hereunder or otherwise in connection with Executive’s employment any amounts required to be deducted and withheld by the Company under the provisions of any applicable
Federal, state and local statute, law, regulation, ordinance or order. 
 Section 9.16 References to
Sections of the Code. All references in this Agreement hereto to sections of the Code shall be to such sections and to any successor or substantially comparable sections of the Code or to any successor thereto. 

  
 -19- 

 Section 9.17 Effect of Delay. Executive’s or
the Company’s failure to insist upon strict compliance with any provision of this Agreement or the failure to assert any right Executive or the Company may have hereunder, including without limitation the right of Executive to terminate
employment for Good Reason pursuant to Section 6.6, shall not be deemed to be a waiver of such provision or right or any other provision or right of this Agreement.  

[Signatures to appear on the following page.] 

  
 -20- 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first written above. 
  

									
	      	 	THE COMPANY	 		 	MP MATERIALS CORP.
					
		 		 		 	By:	 	/s/ James H. Litinsky
		 		 		 		 	 James H. Litinsky
 Chairman of the Board and

Chief Executive Officer

		 	EXECUTIVE	 		 		 	
					
		 		 		 		 	/s/ Elliot D. Hoops
		 		 		 		 	Elliot D. Hoops

 APPENDIX A 

MP MATERIALS CORP. 

INCENTIVE COMPENSATION CLAWBACK POLICY 

1. Overview. MP Materials Corp. (the “Company”) has adopted this Incentive Compensation Clawback Policy
(the “Policy”) in order to help ensure that incentive compensation is paid or awarded based on accurate financial results and the correct calculation of performance against incentive targets. 

2. Compensation Committee. The Compensation Committee (the “Committee”) of the Board of Directors of the
Company (the “Board”) shall have full authority to interpret and enforce the Policy in accordance with its business judgment. 

3. Covered Executives. The Policy applies to all current and former officers (as that term is defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) of the Company and any other current and former employee of the Company and its subsidiaries designated by the Board or the Committee from time to time
by notice to the employee (collectively, the “Covered Employees”). 
 4. Incentive Compensation. For
purposes of the Policy, “incentive compensation” means annual performance bonuses and long-term incentive awards (in each case, including cash, stock options, stock appreciation rights, restricted stock, restricted stock units, performance
share units or other equity-based awards) paid, granted, vested, settled, or accrued. 
 5. Restatement of Financial Results; Calculation
of Overpayment. 
 If the Committee determines, in its discretion, that incentive compensation of a Covered Employee was overpaid, in
whole or in part, as a result of a restatement of the reported financial results of the Company or any of its segments for any reason (other than a change in accounting rules or policy or applicable law), the Committee will review the incentive
compensation paid, granted, vested, settled or accrued based on the prior inaccurate results. 
 To the extent practicable, and as permitted
by and consistent with applicable law, after the Committee has considered the costs and benefits of doing so, the Committee will determine, in its discretion, whether to seek to recover or cancel the difference, on a
pre-tax basis, between (i) any incentive compensation paid, granted, vested, settled or accrued based on the belief that the Company or the segment had met or exceeded performance targets that would not
have been met had the financial information been accurate, and (ii) the incentive compensation in which the Covered Employee would have been paid or awarded based on the accurate financial information or restated results, as applicable (an
“Overpayment”). The Committee may only seek to recover or cancel an Overpayment if the restatement of the reported financial results shall have occurred within 36 months after the publication of the audited financial
statements that have been restated. 
 In making the determination referred to in the preceding paragraph, the Committee shall take into
account such factors as it deems appropriate. 
 6. Forms of Recovery. If the Committee determines to seek recovery for the
Overpayment, the Company shall have the right to demand that the Covered Employee pay the Company for, or forfeit, any Overpayment paid or awarded as a result of a misstatement triggering a restatement of the reported financial results of the
Company or any of its segments. The Committee may also determine to reduce, cancel or cause the forfeiture of any incentive compensation otherwise due to recover the Overpayment, provided, that, any reduction, cancellation or forfeiture of any
incentive compensation shall be in done in compliance with Section 409A of the Internal Revenue Code of 1986, as amended. 

  
 Appendix A-1 

 To the extent the Covered Employee refuses to pay to the Company an amount equal to the
Overpayment, the Company shall have the right to sue for repayment and/or enforce the Covered Employee’s obligation to make payment through the reduction or cancellation of outstanding and future incentive compensation. Without limiting the
Company’s rights, to the extent any shares have been issued under vested awards or such shares have been sold by the Covered Employee, the Company shall have the right to cancel any other outstanding equity-based awards with a value equivalent
to the Overpayment, as determined by the Committee. 
 7. Committee Determination Final. Any determination by the Committee
with respect to the Policy shall be final, conclusive and binding on all interested parties. 
 8. Effectiveness. This Policy
shall apply to all incentive compensation paid or awarded on or after the adoption of this Policy. 
 9. Amendment. The Policy
may be amended by the Committee from time to time, and any provision thereof may be waived by the Committee. 
 10. Non-Exclusivity. Nothing in the Policy shall be viewed as limiting the right of the Company or the Committee to pursue recoupment under or as required by the Company’s plans, awards and employment
agreements or the applicable provisions of any law, rule or regulation (including, without limitation, Section 10D of Securities Exchange Act of 1934, as amended, or Section 304 of the Sarbanes-Oxley Act of 2002), or stock exchange listing
requirement (and any future policy adopted by the Company pursuant to any such law, rule, regulation or requirement). 

  
 Appendix A-2Exhibit 4.4

 

PUBLIC WARRANT
AGREEMENT

 

GENESIS GROWTH
TECH ACQUISITION CORP.

 

and

 

CONTINENTAL STOCK
TRANSFER & TRUST COMPANY

 

Dated [●],
2021

 

THIS WARRANT AGREEMENT (this “Agreement”),
dated [●], 2021, is by and between Genesis Growth Tech Acquisition Corp., a Cayman Islands exempted company (the “Company”),
and Continental Stock Transfer & Trust Company, a New York limited purpose trust company, as warrant agent (in such capacity,
the “Warrant Agent”).

 

WHEREAS, the Company is engaged in an initial public
offering (the “Public Offering”) of units of the Company’s equity securities, each such unit comprised
of one Ordinary Share and one-half of one Public Warrant (as defined below) (the “Units”) and, in connection
therewith, has determined to issue and deliver up to 11,500,000 redeemable warrants (including up to 1,500,000 redeemable warrants subject
to the Over-allotment Option) to public investors in the Public Offering (the “Public Warrants”). Each whole
Public Warrant entitles the holder thereof to purchase one Class A ordinary share of the Company, par value $0.0001 per share (“Ordinary
Shares”), for $11.50 per share, subject to adjustment as described herein. Only whole Public Warrants are exercisable. A
holder of the Public Warrants will not be able to exercise any fraction of a Public Warrant; and

 

WHEREAS, the Company has filed with the Securities
and Exchange Commission (the “Commission”) registration statement on Form S-1, File No. 333-[●], and a
prospectus (the “Prospectus”), for the registration, under the Securities Act of 1933, as amended (the “Securities
Act”), of the Units, the Public Warrants and the Ordinary Shares included in the Units; and

 

WHEREAS, the Company has entered into that certain
Forward Purchase Agreement (the “Forward Purchase Agreement”) with [                           ] (the “Forward Purchaser”),
pursuant to which the Forward Purchaser has committed, subject to approval of its investment committee as well as customary closing conditions,
to purchase up to 2,500,000 warrants (the “Forward Purchase Warrants”, and together with the Public Warrants,
the “Warrants”) included as part of the forward purchase units, each comprised of one Ordinary Share and one-half
of one Forward Purchase Warrant, to be sold to the Forward Purchaser in a private placement transaction to occur at or prior to the time
of the Company’s initial Business Combination (as defined below), bearing the legend set forth in Exhibit B hereto; and

 

WHEREAS, the Company desires the Warrant Agent
to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer,
exchange, redemption and exercise of the Warrants; and

 

WHEREAS, the Company desires to provide for the
form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of
rights, and immunities of the Company, the Warrant Agent and the holders of the Warrants; and

 

WHEREAS, all acts and things have been done and
performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant
Agent (if a physical certificate is issued), as provided herein, the valid, binding and legal obligations of the Company, and to authorize
the execution and delivery of this Agreement.

 

     

     

    

 

NOW, THEREFORE, in consideration of the mutual
agreements herein contained, the parties hereto agree as follows:

 

1. 
Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants,
and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth
in this Agreement.

 

2. 
Warrants.

 

2.1 
Form of Warrant. Each Warrant shall initially be issued in registered form only.

 

2.2 
Effect of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant
to this Agreement, a certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.3 
Registration.

 

2.3.1 
Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration
of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants in book-entry form, the
Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise
in accordance with instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Warrants shall
be shown on, and the transfer of such ownership shall be effected through, records maintained by institutions that have accounts with
The Depository Trust Company (the “Depositary”) (such institution, with respect to a Warrant in its account,
a “Participant”).

 

If the Depositary subsequently ceases to make its
book-entry settlement system available for the Warrants, the Company may instruct the Warrant Agent regarding making other arrangements
for book-entry settlement. In the event that the Warrants are not eligible for, or it is no longer necessary to have the Warrants available
in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver to the Warrant Agent for cancellation
each book-entry Warrant, and the Company shall instruct the Warrant Agent to deliver to the Depositary definitive certificates in physical
form evidencing such Warrants (“Definitive Warrant Certificates”) which shall be in the form annexed hereto
as Exhibit A.

 

Physical certificates, if issued, shall be signed
by, or bear the facsimile signature of, the Chairman of the Company’s board of directors (the “Board”),
Chief Executive Officer, Chief Financial Officer or other principal officer of the Company. In the event the person whose facsimile signature
has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant
is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.

 

2.3.2 
Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent
may deem and treat the person in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby, for the purpose of any exercise thereof, and for all other
purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.4 
Detachability of Warrants. The Ordinary Shares and Warrants comprising the Units shall begin separate trading on the 52nd
day following the date of the Prospectus or, if such 52nd day is not on a day, other than a Saturday, Sunday or federal holiday, on which
banks in New York City are generally open for normal business (a “Business Day”), then on the immediately succeeding
Business Day following such date, or earlier (the “Detachment Date”) with the consent of Nomura Securities International,
Inc., but in no event shall the Ordinary Shares and the Warrants comprising the Units be separately traded until (A) the Company
has filed a Current Report on Form 8-K with the Commission containing an audited balance sheet reflecting the receipt by the Company of
the gross proceeds of the Public Offering, including the proceeds then received by the Company from the exercise by the underwriters of
their right to purchase additional Units in the Public Offering (the “Over-allotment Option”), if the Over-allotment
Option is exercised prior to the filing of the Current Report on Form 8-K, and (B) the Company issues a press release announcing
when such separate trading shall begin.

 

    Page 1

     

    

 

2.5 
Fractional Warrants. The Company shall not issue fractional Warrants other than as part of the Units, each of which is comprised
of one Ordinary Share and one-half of one whole Warrant. If, upon the detachment of Warrants from the Units or otherwise, a holder of
Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number the number of Warrants
to be issued to such holder.

 

2.6 
Forward Purchase Warrants. Each of the Forward Purchase Warrants shall be identical to the Public Warrants, except for certain
transfer restrictions and registration rights as described in the Forward Purchase Agreement.

 

3. 
Terms and Exercise of Warrants.

 

3.1 
Warrant Price. Each whole Warrant shall entitle the Registered Holder thereof, subject to the provisions of such Warrant
and of this Agreement, to purchase from the Company the number of Ordinary Shares stated therein, at the price of $11.50 per share, subject
to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant
Price” as used in this Agreement shall mean the price per share (including in cash or by payment of Warrants pursuant to
a “cashless exercise,” to the extent permitted hereunder) described in the prior sentence at which Ordinary Shares may be
purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the
Expiration Date (as defined below) for a period of not less than fifteen Business Days (unless otherwise required by the Commission, any
national securities exchange on which the Warrants are listed or applicable law); provided that the Company shall provide at least five
days’ prior written notice of such reduction to Registered Holders of the Warrants; and provided further, that any such reduction
shall be identical among all of the Warrants.

 

3.2 
Duration of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”)
(A) commencing on the date that is thirty (30) days after the first date on which the Company completes its initial merger, share
exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more businesses
(a “Business Combination”), and (B) terminating at the earliest to occur of (x) 5:00 p.m., New York City
time on the date that is five (5) years after the date on which the Company completes its initial Business Combination, (y) the
liquidation of the Company in accordance with the Company’s amended and restated memorandum and articles of association, as amended
from time to time, if the Company fails to complete a Business Combination, and (z) 5:00 p.m., New York City time on the Redemption
Date (as defined below) as provided in Section 6.2 hereof (the “Expiration Date”); provided, however,
that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2
below, with respect to an effective registration statement or a valid exemption therefrom being available. Except with respect to the
right to receive the Redemption Price (as defined below) in the event of a redemption (as set forth in Section 6 hereof),
each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof
under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend
the duration of the Warrants by delaying the Expiration Date; provided that the Company shall provide at least twenty (20) days prior
written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical
in duration among all the Warrants.

 

3.3 
Exercise of Warrants.

 

3.3.1 
Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant may be exercised by the Registered Holder
thereof by delivering to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing the
Warrants to be exercised, or, in the case of a Warrant represented by a book-entry, the Warrants to be exercised (the “Book-Entry
Warrants”) on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes
in writing by the Warrant Agent to the Depositary from time to time, (ii) an election to purchase (“Election to Purchase”)
any Ordinary Shares pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of
the Definitive Warrant Certificate or, in the case of a Book-Entry Warrant, properly delivered by the Participant in accordance with the
Depositary’s procedures, and (iii) the payment in full of the Warrant Price for each Ordinary Share as to which the Warrant
is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the
Ordinary Shares and the issuance of such Ordinary Shares, as follows:

 

(a) 
in lawful money of the United States, in good certified check or good bank draft payable to the order of the Warrant Agent;

 

    Page 2

     

    

 

(b) 
in the event of a redemption pursuant to Section 6.1 hereof in which the Board has elected to require all holders of the
Warrants to exercise such warrants on a “cashless basis” by surrendering the warrants for that number of Ordinary Shares equal
to the quotient obtained by dividing (x) the product of the number of Ordinary Shares underlying the Warrants, multiplied by the
difference between the Warrant Price and the “Redemption Fair Market Value” (as defined in this subsection 3.3.1(b))
by (y) the Redemption Fair Market Value. The Redemption Fair Market Value shall mean the average reported last sale price of the
Ordinary Shares for the five trading days ending on the third trading day prior to the date on which the notice of redemption is
sent to the holders of warrants, pursuant to Section 6.2 hereof; or

 

(c) 
as provided in Section 7.4 hereof.

 

3.3.2 
Issuance of Ordinary Shares on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the
funds in payment of the Warrant Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered
Holder of such Warrant a book-entry position or certificate, as applicable, for the number of Ordinary Shares to which he, she or it is
entitled, registered in such name or names as may be directed by him, her or it on the register of members of the Company, and if such
Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares
as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any
Ordinary Shares pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless (i) a registration
statement under the Securities Act with respect to the Ordinary Shares underlying the Warrants is then effective and a prospectus relating
thereto is current, subject to the Company’s satisfying its obligations under Section 7.4 or (ii) a valid exemption
from registration is available. No Warrant shall be exercisable and the Company shall not be obligated to issue Ordinary Shares upon exercise
of a Warrant unless the Ordinary Shares issuable upon such Warrant exercise have been registered, qualified or deemed to be exempt from
registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. In the event
that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant
shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless, in which case the purchaser of
a Unit containing such Warrants shall have paid the full purchase price for the Unit solely for the Ordinary Shares underlying such Unit.
Subject to Section 4.7 of this Agreement, a Registered Holder of Warrants may exercise its Warrants only for a whole number
of Ordinary Shares. The Company may require holders of Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4.
If, by reason of any exercise of Warrants on a “cashless basis”, the holder of any Warrant would be entitled, upon the
exercise of such Warrant, to receive a fractional interest in an Ordinary Share, the Company shall round down to the nearest whole number,
the number of Ordinary Shares to be issued to such holder. For the avoidance of doubt, in no event will the Company be required to pay
cash to the holder of any Warrant.

 

3.3.3 
Valid Issuance. All Ordinary Shares issued upon the proper exercise of a Warrant in conformity with this Agreement shall
be validly issued, fully paid and nonassessable.

 

3.3.4 
Date of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for Ordinary Shares is
issued and who is registered in the register of members of the Company shall for all purposes be deemed to have become the holder of record
of such Ordinary Shares on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment
of the Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except
that, if the date of such surrender and payment is a date when the register of members of the Company or book-entry system of the Warrant
Agent are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding
date on which the share transfer books or book-entry system are open.

 

    Page 3

     

    

 

3.3.5 
Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the
provisions contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5
unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the
holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such
exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially
own in excess of 9.8% (the “Maximum Percentage”) of the Ordinary Shares outstanding immediately after giving
effect to such exercise. For purposes of the foregoing sentence, the aggregate number of Ordinary Shares beneficially owned by such person
and its affiliates shall include the number of Ordinary Shares issuable upon exercise of the Warrant with respect to which the determination
of such sentence is being made, but shall exclude Ordinary Shares that would be issuable upon (x) exercise of the remaining, unexercised
portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or
unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation,
any convertible notes or convertible preferred shares or warrants) subject to a limitation on conversion or exercise analogous to the
limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall
be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
For purposes of the Warrant, in determining the number of outstanding Ordinary Shares, the holder may rely on the number of outstanding
Ordinary Shares as reflected in (1) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current
Report on Form 8-K or other public filing with the Commission as the case may be, (2) a more recent public announcement by the Company
or (3) any other notice by the Company or Continental Stock Transfer & Trust Company, as transfer agent (in such capacity,
the “Transfer Agent”), setting forth the number of Ordinary Shares outstanding. For any reason at any time,
upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing
to such holder the number of Ordinary Shares then outstanding. In any case, the number of issued and outstanding Ordinary Shares shall
be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates since
the date as of which such number of issued and outstanding Ordinary Shares was reported. By written notice to the Company, the holder
of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified
in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after
such notice is delivered to the Company.

 

4. 
Adjustments.

 

4.1 
Share Capitalizations.

 

4.1.1 
Sub-Divisions. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of issued
and outstanding Ordinary Shares is increased by a capitalization or share dividend of Ordinary Shares, or by a sub-division of Ordinary
Shares or other similar event, then, on the effective date of such share capitalization, sub-division or similar event, the number of
Ordinary Shares issuable on exercise of each Warrant shall be increased in proportion to such increase in the issued and outstanding Ordinary
Shares. A rights offering made to all or substantially all holders of Ordinary Shares entitling holders to purchase Ordinary Shares at
a price less than the Historical Fair Market Value (as defined below) shall be deemed a capitalization of a number of Ordinary Shares
equal to the product of (i) the number of Ordinary Shares actually sold in such rights offering (or issuable under any other equity
securities sold in such rights offering that are convertible into or exercisable for the Ordinary Shares) multiplied by (ii) one
(1) minus the quotient of (x) the price per Ordinary Share paid in such rights offering divided by (y) the Historical Fair Market
Value. For purposes of this subsection 4.1.1, if the rights offering is for securities convertible into or exercisable for
Ordinary Shares, in determining the price payable for Ordinary Shares, there shall be taken into account any consideration received for
such rights, as well as any additional amount payable upon exercise or conversion. “10-Day VWAP” means, as of
any date, the volume weighted average price of the Ordinary Shares during the ten (10) trading day period ending on the trading day
prior to such date. “Historical Fair Market Value” means the 10-Day VWAP as of the first date on which the Ordinary
Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. Notwithstanding
anything to the contrary herein, no Ordinary Shares shall be issued at less than their par value.

 

    Page 4

     

    

 

4.1.2 
Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, pays to all or substantially
all of the holders of the Ordinary Shares a dividend or make a distribution in cash, securities or other assets on account of such Ordinary
Shares (or other shares into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above,
(b) Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the holders of the Ordinary Shares in connection
with a proposed initial Business Combination, (d) to satisfy the redemption rights of the holders of the Ordinary Shares in connection
with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (i) to modify the
substance or timing of the Company’s obligation to provide holders of Ordinary Shares the right to have their shares redeemed in
connection with the Company’s initial Business Combination or to redeem 100% of the Company’s public shares if it does not
complete its initial Business Combination within the time period required by the Company’s Amended and Restated Memorandum and Articles
of Association, as amended from time to time, or (ii) with respect to any other provision relating to the rights of holders of Ordinary
Shares, (e) as a result of the repurchase of Ordinary Shares by the Company if a proposed initial Business Combination is presented
to the shareholders of the Company for approval or (f) in connection with the redemption of public shares upon the failure of the
Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation (any such non-excluded
event being referred to herein as an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective
immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined
by the Company’s Board, in good faith) of any securities or other assets paid on each Ordinary Share in respect of such Extraordinary
Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend
or cash distribution which, when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions
paid on the Ordinary Shares during the 365-day period ending on the date of declaration of such dividend or distribution to the extent
it does not exceed $0.50 (which amount shall be adjusted to appropriately reflect any of the events referred to in other subsections of
this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to
the number of Ordinary Shares issuable on exercise of each Warrant).

 

4.2 
Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number
of issued and outstanding Ordinary Shares is decreased by a consolidation, combination, reverse share split or reclassification of Ordinary
Shares or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or
similar event, the number of Ordinary Shares issuable on exercise of each Warrant shall be decreased in proportion to such decrease in
issued and outstanding Ordinary Shares.

 

4.3 
Adjustments in Exercise Price. Whenever the number of Ordinary Shares purchasable upon the exercise of the Warrants is adjusted,
as provided in subsection 4.1.1 or Section 4.2 above, the Warrant Price shall be adjusted (to the nearest cent)
by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number
of Ordinary Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of
which shall be the number of Ordinary Shares so purchasable immediately thereafter.

 

4.4 
Raising of the Capital in Connection with the Initial Business Combination. If (x) the Company issues additional Ordinary
Shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at
an issue price or effective issue price of less than $9.20 per Ordinary Share (with such issue price or effective issue price to be determined
in good faith by the Board and, in the case of any such issuance to Genesis Growth Tech LLC, a Cayman Islands limited liability company
(the “Sponsor”), or its affiliates, without taking into account any Class B ordinary shares, par value
$0.0001 per share, of the Company held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly
Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds,
and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the completion of the
Company’s initial Business Combination (net of redemptions), and (z) the 10-day VWAP as of the day on which the Company consummates
its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price
shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per
share redemption trigger price described in Section 6.1.1 shall be adjusted (to the nearest cent) to be equal to 180% of the
higher of the Market Value and the Newly Issued Price.

 

    Page 5

     

    

 

4.5 
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the issued and
outstanding Ordinary Shares (other than a change covered by Section 4.1 or Section 4.2 hereof or that solely affects
the par value of such Ordinary Shares), or in the case of any merger or consolidation of the Company with or into another entity in which
any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act) acquires more
than 50% of the voting power of the Company’s securities, or in the case of any sale or conveyance to another corporation or entity
of the assets or other property of the Company as an entirety or substantially as an entirety, the holders of the Warrants shall thereafter
have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the
Ordinary Shares of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby,
the kind and amount of shares or stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have received
if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”);
provided, however, that if the holders of the Ordinary Shares were entitled to exercise a right of election as to the kind or amount of
securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets
constituting the Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the
kind and amount received per share by the holders of the Ordinary Shares in such consolidation or merger that affirmatively make such
election; provided further that if less than 70% of the consideration receivable by the holders of the Ordinary Shares in the applicable
event is payable in the form of shares in the successor entity that is listed for trading on a national securities exchange or is quoted
in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered
Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable
event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be reduced by an amount
(in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share
Consideration (as defined below) (but in no event less than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The
“Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable
event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (assuming zero dividends) (“Bloomberg”).
For purposes of calculating such amount, (i) Section 6.1 of this Agreement shall be taken into account for purposes of
the Warrants, (ii) the price of each Ordinary Share shall be the volume weighted average price of the Ordinary Shares during the
ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (iii) the assumed
volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior
to the day of the announcement of the applicable event and (iv) the assumed risk-free interest rate shall correspond to the U.S.
Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if
the consideration paid to holders of the Ordinary Shares consists exclusively of cash, the amount of such cash per Ordinary Share, and
(ii) in all other cases, the volume weighted average price of the Ordinary Shares during the ten (10) trading day period ending
on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change
in Ordinary Shares covered by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1
or Sections 4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4 shall similarly
apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event shall the Warrant
Price be reduced to less than the par value per share issuable upon exercise of such Warrant.

 

4.6 
Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise
of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting
from such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant,
setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of
any event specified in Sections 4.1, 4.2, 4.3, 4.4 or 4.5, the Company shall give written notice
of the occurrence of such event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of
the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality
or validity of such event.

 

4.7 
No Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue
fractional shares upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder
of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon
such exercise, round down to the nearest whole number the number of Ordinary Shares to be issued to such holder.

 

    Page 6

     

    

 

4.8 
Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4,
and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants
initially issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change
in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter
issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

5. 
Transfer and Exchange of Warrants.

 

5.1 
Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon
the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied
by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall
be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled
shall be delivered by the Warrant Agent to the Company from time to time upon request.

 

5.2 
Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for
exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered
Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that except as otherwise
provided herein or with respect to any Book-Entry Warrant, each Book-Entry Warrant may be transferred only in whole and only to the Depositary,
to another nominee of the Depositary, to a successor depository, or to a nominee of a successor depository; provided further, however
that in the event that a Warrant surrendered for transfer bears a restrictive legend (as in the case, initially, of the Forward Purchase
Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received
an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a
restrictive legend.

 

5.3 
Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall
result in the issuance of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

 

5.4 
Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5 
Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance
with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the
Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for
such purpose.

 

5.6 
Transfer of Warrants. Prior to the Detachment Date, the Warrants may be transferred or exchanged only together with the
Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such
Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included
in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants
on and after the Detachment Date.

 

6. 
Redemption.

 

6.1 
Redemption of Warrants for Cash. All, but not less than all, of the outstanding Warrants may be redeemed for cash, at the
option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders
of the Warrants, as described in Section 6.2 below, at a Redemption Price of $0.01 per Warrant, provided that (a) the
Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with Section 4 hereof) and (b) there
is an effective registration statement covering the issuance of the Ordinary Shares issuable upon exercise of the Warrants, and a current
prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.2 below) or the Company
has elected to require the exercise of warrants on a “cashless basis” pursuant to subsection 3.3.1(b) hereof.

 

    Page 7

     

    

 

6.2 
Date Fixed for, and Notice of, Redemption; Redemption Price; Reference Value. In the event that the Company elects to redeem
the Warrants pursuant to Section 6.1, the Company shall fix a date for the redemption (the “Redemption Date”).
Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to
the Redemption Date (the “30-day Redemption Period”) to the Registered Holders of the Warrants to be redeemed
at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively
presumed to have been duly given whether or not the Registered Holder received such notice. As used in this Agreement, (a) “Redemption
Price” shall mean the price per Warrant at which any Warrants are redeemed pursuant to Section 6.1 and (b) “Reference
Value” shall mean the 10-Day VWAP as of the date on which notice of redemption is given.

 

6.3 
Exercise After Notice of Redemption. The Warrants may be exercised for cash (or on a “cashless basis” pursuant
to subsection 3.3.1(b) hereof, if applicable) at any time after notice of redemption shall have been given by the Company pursuant
to Section 6.2 hereof and prior to the Redemption Date. In the event that the Company determines to require all holders of
Warrants to exercise their Warrants on a “cashless basis” pursuant to subsection 3.3.1(b) hereof, the notice of redemption
shall contain instructions on how to calculate the number of Ordinary Shares to be received upon exercise of the Warrants. On and after
the Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants,
the Redemption Price.

 

7. 
Other Provisions Relating to Rights of Holders of Warrants.

 

7.1 
No Rights as Shareholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a shareholder
of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights,
to vote or to consent or to receive notice as shareholders in respect of the meetings of shareholders or the election of directors of
the Company or any other matter.

 

7.2 
Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and
the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a
mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen,
mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the
allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3 
Reservation of Ordinary Shares. The Company shall at all times reserve and keep available a number of its authorized but
unissued Ordinary Shares that shall be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4 
Registration of Ordinary Shares; Cashless Exercise at Company’s Option.

 

7.4.1 
Registration of the Ordinary Shares. The Company agrees that as soon as practicable, but in no event later than twenty (20) Business
Days after the closing of its initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission
a post-effective amendment to the registration statement relating to the Public Offering or a new registration statement for the registration,
under the Securities Act, of the Ordinary Shares issuable upon exercise of the Warrants. The Company shall use its commercially reasonable
efforts to cause the same to become effective within sixty (60) Business Days following the closing of its initial Business Combination
and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption
of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective
by the sixtieth (60th) Business Day following the closing of the Business Combination, holders of the Warrants shall
have the right, during the period beginning on the sixty-first (61st) Business Day after the closing of the Business
Combination and ending upon such registration statement being declared effective by the Commission, and during any other period when the
Company shall fail to have maintained an effective registration statement covering the issuance of the Ordinary Shares issuable upon exercise
of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the Warrants (in accordance with Section 3(a)(9)
of the Securities Act or another exemption) for that number of Ordinary Shares per Warrant equal to (A) the quotient obtained by
dividing (x) the product of the number of Ordinary Shares underlying the warrants, multiplied by the excess of the Exercise Fair Market
Value (as defined in this subsection 7.4.1) over the Warrant Price by (y) the Exercise Fair Market Value. The “Exercise
Fair Market Value” means the 10-Day VWAP of the Ordinary Shares for the 10 trading days ending on the trading day prior to the date
on which the notice of exercise is received by the Warrant Agent. The date that notice of “cashless exercise” is received
by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of
a Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside
law firm with securities law experience) stating that (i) the exercise of the Warrants on a “cashless basis” in accordance
with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the Ordinary Shares issued
upon such exercise shall be freely tradable under United States federal securities laws by anyone who is not an affiliate (as such term
is defined in Rule 144 under the Securities Act) of the Company and, accordingly, shall not be required to bear a restrictive legend.
Except as provided in subsection 7.4.2, for the avoidance of doubt, unless and until all of the Warrants have been exercised
or have expired, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences
of this subsection 7.4.1.

 

    Page 8

     

    

 

7.4.2 
Cashless Exercise at Company’s Option. If the Ordinary Shares are at the time of any exercise of a Warrant not listed
on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1)
of the Securities Act, the Company may, at its option, (i) require holders of Warrants who exercise Warrants to exercise such Warrants
on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act as described in subsection 7.4.1
and (ii) in the event the Company so elects, the Company shall (x) not be required to file or maintain in effect a registration
statement for the registration, under the Securities Act, of the Ordinary Shares issuable upon exercise of the Warrants, notwithstanding
anything in this Agreement to the contrary, and (y) use its commercially reasonable efforts to register or qualify for sale the Ordinary
Shares issuable upon exercise of the Warrant under applicable blue sky laws to the extent an exemption is not available. To exercise the
Warrants on a cashless basis pursuant to this subsection 7.4.2, each Registered Holder would pay the Warrant Price by surrendering
the Warrants in exchange for a number of Ordinary Shares equal to the quotient obtained by dividing (i) the product of (A) the number
of the Ordinary Shares underlying the Warrants and (B) the excess of the Exercise Fair Market Value over the Warrant Price of the Warrants
by (ii) the Exercise Fair Market Value.

 

8. 
Concerning the Warrant Agent and Other Matters.

 

8.1 
Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company
or the Warrant Agent in respect of the issuance or delivery of Ordinary Shares upon the exercise of the Warrants, but the Company shall
not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

8.2 
Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1 
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties
and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the
Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint
in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period
of thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder
of a Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant
may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at
the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other
entity organized and existing under the laws of the State of New York, in good standing and having its principal office in the United
States of America, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal
or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities,
duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any
further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver,
at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such
predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and
deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all
such authority, powers, rights, immunities, duties, and obligations.

 

    Page 9

     

    

 

8.2.2 
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice
thereof to the predecessor Warrant Agent and the Transfer Agent for the Ordinary Shares not later than the effective date of any such
appointment.

 

8.2.3 
Merger or Consolidation of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be
consolidated or any entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor
Warrant Agent under this Agreement without any further act.

 

8.3 
Fees and Expenses of Warrant Agent.

 

8.3.1 
Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent
hereunder and shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that
the Warrant Agent may reasonably incur in the execution of its duties hereunder.

 

8.3.2 
Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed,
acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant
Agent for the carrying out or performing of the provisions of this Agreement.

 

8.4 
Liability of Warrant Agent.

 

8.4.1 
Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem
it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder,
such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved
and established by a statement signed by the Chief Executive Officer, the Chief Financial Officer or the Chairman of the Board of the
Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith
by it pursuant to the provisions of this Agreement.

 

8.4.2 
Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct, fraud or bad
faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket
costs and reasonable outside counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement, except
as a result of the Warrant Agent’s gross negligence, willful misconduct, fraud or bad faith.

 

8.4.3 
Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect
to the validity or execution of any Warrant (except its countersignature thereof). The Warrant Agent shall not be responsible for any
breach by the Company of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible
to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount
of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder
be deemed to make any representation or warranty as to the authorization or reservation of any Ordinary Shares to be issued pursuant to
this Agreement or any Warrant or as to whether any Ordinary Shares shall, when issued, be valid and fully paid and nonassessable.

 

    Page 10

     

    

 

8.5 
Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the
same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants
exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of Ordinary
Shares through the exercise of the Warrants.

 

8.6 
Waiver. The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”)
in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date
hereof, by and between the Company and Continental Stock Transfer & Trust Company as trustee thereunder) and hereby agrees not
to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant
Agent hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

 

9. 
Miscellaneous Provisions.

 

9.1 
Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent
shall bind and inure to the benefit of their respective successors and assigns.

 

9.2 
Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the
holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by
certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another
address is filed in writing by the Company with the Warrant Agent), as follows:

 

Genesis Growth Tech Acquisition Corp.

 

Bahnhofstrasse 3, 6052 Hergiswil

Nidwalden, Switzerland

Attention: Eyal Perez

 

with a copy to:

 

Orrick, Herrington & Sutcliffe LLP

222 Berkeley Street, Suite 2000

Boston, MA 02116

Attention: Albert Vanderlaan

 

Any notice, statement or demand authorized by this Agreement to be
given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered
if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such
notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

 

Continental Stock Transfer & Trust Company

One State Street, 30th Floor

New York, NY 10004

Attention:Compliance Department

 

9.3 
Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants
shall be governed in all respects by the laws of the State of New York. Subject to applicable law, the Company hereby agrees that any
action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts
of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction,
which jurisdiction shall be exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such
exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph
will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal
district courts of the United States of America are the sole and exclusive forum.

 

    Page 11

     

    

 

Any person or entity purchasing or otherwise acquiring
any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3.
If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than a court located
within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”)
in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the
state and federal courts located within the State of New York or the United States District Court for the Southern District of New York
in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”),
and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s
counsel in the foreign action as agent for such warrant holder.

 

9.4 
Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any
person, corporation or other entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim
under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions,
stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and
their successors and assigns and of the Registered Holders of the Warrants.

 

9.5 
Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office
of the Warrant Agent in the United States of America, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require
any such holder to submit such holder’s Warrant for inspection by the Warrant Agent.

 

9.6 
Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7 
Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not
affect the interpretation thereof.

 

9.8 
Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose
of (i) curing any ambiguity or to correct any mistake, including to conform the provisions hereof to the description of the terms
of the Warrants and this Agreement set forth in the Prospectus, or defective provision contained herein, (ii) amending the definition
of “Ordinary Cash Dividend” as contemplated by and in accordance with the second sentence of subsection 4.1.2
or (iii) adding or changing any provisions with respect to matters or questions arising under this Agreement as the parties may deem
necessary or desirable and that the parties deem shall not adversely affect the rights of the Registered Holders under this Agreement.
All other modifications or amendments, including any modification or amendment to increase the Warrant Price or shorten the Exercise Period,
shall require the vote or written consent of the Registered Holders of 65% of the then-outstanding Warrants. Any amendment to the terms
of the Forward Purchase Warrants or any provision of this Agreement with respect to the Forward Purchase Warrants shall require at least
65% of the then outstanding Forward Purchase Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend
the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the Registered
Holders.

 

9.9 
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision
hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu
of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement
a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

    Page 12

     

    

 

IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be duly executed as of the date first above written.

 

	 	Genesis Growth Tech Acquisition Corp.
	 	 	 	 
	 	By:	 
	 	 	Name: 	Eyal Perez
	 	 	Title:	Chief Executive Officer
	 	 	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY,
	 	as Warrant Agent
	 	 	 	 
	 	By:	 
	 	 	Name:	 
	 	 	Title:	 

 

     

     

    

 

Exhibit A — Form of Warrant Certificate

 

     

     

    

 

Exhibit B — Legend for Forward Purchase Warrants

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]